<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Supraventricular premature beats</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Supraventricular premature beats</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Supraventricular premature beats</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Antonis S Manolis, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Hugh Calkins, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 27, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Supraventricular premature beats represent premature activation of the atria from a site other than the sinus node and can originate from the atria (premature atrial complexes [PACs]; also referred to as premature atrial beats, premature supraventricular complexes, or premature supraventricular beats) or the atrioventricular node (called junctional premature beats [JPBs]), though the vast majority are atrial in origin. PACs are triggered from the atrial myocardium in a variety of situations and occur in a broad spectrum of the population. This includes patients without structural heart disease and those with any form of cardiac disease, independent of severity.</p><p>The prevalence, mechanisms, clinical manifestations, diagnosis, and treatment of PACs will be presented here. A discussion of premature ventricular complex/contraction (PVC; also referred to a premature ventricular beats or premature ventricular depolarizations) is presented separately. (See  <a class="medical medical_review" href="/z/d/html/994.html" rel="external">"Premature ventricular complexes: Clinical presentation and diagnostic evaluation"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">PREVALENCE</span><span class="headingEndMark"> — </span>PACs are fairly ubiquitous, occurring commonly in both young and older adult subjects and in those with and without significant heart disease.</p><p>The prevalence of PACs is highly dependent upon the technique used for evaluation. PACs are less commonly seen on standard 10-second electrocardiogram (ECG) compared with 24-hour or longer duration Holter monitoring. In a cross-sectional analysis of 1742 Swiss adults (50 years of age or older) from the general population who underwent Holter monitoring for 24 hours, 99 percent had at least one PAC during the monitoring period [<a href="#rid1">1</a>]. In this Swiss cohort, the frequency of PACs steadily increased with age, with rates of 0.8, 1.4, and 2.6 PACs per hour among participants aged 50 to 55 years, 60 to 65 years, and 70 or more years, respectively [<a href="#rid1">1</a>]. Similar findings of greater PAC frequency with advancing age have been reported in other cohorts as well [<a href="#rid2">2-4</a>].</p><p>The presence and frequency of PACs is dependent upon the presence of structural heart disease. PACs are particularly frequent in patients with mitral valve disease and in those with left ventricular dysfunction regardless of etiology. However, the high prevalence of PACs in the normal population makes such associations uncertain. (See <a class="local">'Etiology'</a> below.)</p><p>The wide range in the reported prevalence of PACs in different populations may be related to the day-to-day variability in their prevalence and frequency. Circadian variation in the frequency of PACs may also occur, but there is significant interpatient variation. In the Copenhagen Holter Study cohort, in which 638 persons (ages 55 to 75 years) underwent up to 48-hour Holter recording and were followed for a median of 14 years, a circadian variation was observed in the group with frequent PACs (≥720/day; n = 66 persons), with the fewest PACs/h observed during the night with a nadir at 6 AM and then reaching a peak value in the afternoon at 3 PM. Runs of PACs in all subjects showed a similar circadian variation, while the risk of atrial fibrillation (AF) was equal in all time intervals throughout the day [<a href="#rid5">5</a>].</p><p>Junctional premature beats (JPBs) occur less commonly than both PACs and PVCs and are rarely seen in clinical practice. Their prevalence has not been well studied due in part to their scarcity as well as difficulty in making the correct diagnosis. In addition, many studies combine JPBs and PACs into one category of supraventricular premature beats.</p><p class="headingAnchor" id="H538018031"><span class="h1">MECHANISMS</span><span class="headingEndMark"> — </span>Since invasive testing is rarely performed in patients with only simple PACs, there is little information about the mechanisms of PACs in humans. Although the mechanisms responsible for spontaneous PACs are not clear or well investigated, it seems likely that multiple mechanisms are responsible for PACs in different patients, depending upon the clinical situation. Possible mechanisms, which are discussed in greater detail elsewhere, include:</p><p class="bulletIndent1"><span class="glyph">●</span>Reentry within the atrium [<a href="#rid6">6</a>] (see  <a class="medical medical_review" href="/z/d/html/954.html" rel="external">"Reentry and the development of cardiac arrhythmias"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal automaticity [<a href="#rid7">7</a>] (see  <a class="medical medical_review" href="/z/d/html/952.html" rel="external">"Enhanced cardiac automaticity"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Triggered activity [<a href="#rid8">8</a>] (see  <a class="medical medical_review" href="/z/d/html/994.html" rel="external">"Premature ventricular complexes: Clinical presentation and diagnostic evaluation", section on 'Mechanisms for PVCs'</a>)</p><p></p><p>Although the mechanisms responsible for JPBs are not clear or well investigated, they are most likely due to abnormal automaticity. (See  <a class="medical medical_review" href="/z/d/html/952.html" rel="external">"Enhanced cardiac automaticity"</a>.)</p><p class="headingAnchor" id="H5"><span class="h1">ETIOLOGY</span></p><p class="headingAnchor" id="H3931447711"><span class="h2">PACs</span><span class="headingEndMark"> — </span>Because PACs occur frequently in subjects with normal hearts as well as in persons with known cardiovascular disease, it is difficult to establish a definite relationship to other disorders or to delineate the factors that predispose to these extra beats. Furthermore, the incidence of PACs is variable in different forms of structural heart disease.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Idiopathic PACs</strong> – In patients without structural heart disease, PACs frequently originate from the pulmonary veins. PACs have long been observed to precede the degeneration of sinus rhythm into AF and are thus considered the main triggers of this common arrhythmia [<a href="#rid9">9,10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lifestyle risk factors</strong> – Smoking, alcohol, and coffee are widely considered as potential precipitants of PACs [<a href="#rid11">11-13</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Smoking and alcohol are known to increase sympathetic tone, which may affect the frequency of PACs [<a href="#rid11">11,12</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Although there is a widespread belief that caffeine, particularly at high doses, is associated with palpitations and a number of arrhythmias, there is no evidence that it is proarrhythmic [<a href="#rid14">14,15</a>]. Caffeine has clear electrophysiologic effects on the atria, although the association with PACs is uncertain [<a href="#rid13">13</a>]. In a study of 1388 participants in the Cardiovascular Health Study, in which caffeine consumption was self-reported and patients underwent 24-hour ambulatory monitoring, there was no significant differences in the frequency of PACs between users and non-users of caffeine [<a href="#rid16">16</a>]. Nevertheless, there are patients who may be more sensitive to caffeine and note a relationship of palpitations to caffeine intake. <a class="drug drug_general" data-topicid="10281" href="/z/d/drug information/10281.html" rel="external">Theophylline</a>, another methylxanthine compound, also may increase PAC frequency [<a href="#rid17">17,18</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Obesity and poor physical activity in midlife have been associated with a higher frequency of PACs in late life [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute myocardial infarction</strong> – Patients with an acute myocardial infarction (MI) have an early increase in the frequency of PACs, with an incidence ranging from 25 to 81 percent [<a href="#rid1">1,20,21</a>]. One study noted a mean of 9 to 14 PACs per hour on day 1 post-MI, which decreased to one to two PACs per hour on day 10 post-MI [<a href="#rid20">20</a>]. Paroxysmal supraventricular tachycardia (PSVT) is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/82.html" rel="external">"Supraventricular arrhythmias after myocardial infarction"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Coronary heart disease</strong> – Among patients with known or suspected coronary heart disease, PACs can be induced during exercise testing, but the prognostic importance of PACs during exercise testing remains unknown [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/z/d/html/1548.html" rel="external">"Prognostic features of stress testing in patients with known or suspected coronary disease", section on 'Atrial arrhythmias'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other heart diseases</strong> – The frequency of PACs appears to be increased in mitral stenosis, hypertrophic cardiomyopathy, and any condition that results in an elevation in pressure or dilatation of the right or left atrium including cardiomyopathy and valvular heart disease [<a href="#rid23">23,24</a>].</p><p></p><p class="bulletIndent1">Some studies have suggested the existence of an atrial myopathy as the underlying disease in patients with and without AF. The concept is that aging, atrial stretching, and/or inflammation may produce atrial remodeling, which may lead to left atrial thrombogenesis in some patients even in the absence of AF [<a href="#rid25">25,26</a>].</p><p></p><p class="bulletIndent1">Apart from echocardiographic indices and possible biomarkers of inflammation, fibrosis, and endothelial dysfunction, recordings of frequent or excessive burden of PACs (≥30 PACs/h daily or ≥200 PACs/24 h, or any runs of ≥20 PACs) might constitute an ECG marker of such myopathy [<a href="#rid26">26-29</a>]. On the other hand, some investigators have suggested that frequent PACs impair left atrial contractile function and promote adverse atrial remodeling and may thus be responsible for the development of atrial myopathy [<a href="#rid30">30</a>].</p><p></p><p class="bulletIndent1">In addition, cardiac amyloidosis, particularly atrial amyloidosis, a form of senile amyloidosis, may be another type of atrial myopathy causing frequent PACs that may lead to AF, mostly in older individuals [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/z/d/html/122846.html" rel="external">"Cardiac amyloidosis: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chronic obstructive pulmonary disease (COPD)</strong> – In patients with COPD, bronchodilator use has been identified as a significant risk factor for increased PACs [<a href="#rid31">31</a>].</p><p></p><p class="headingAnchor" id="H1602688560"><span class="h2">JPBs</span><span class="headingEndMark"> — </span>JPBs may occur in subjects with normal or abnormal hearts. Their presence may be increased by hypokalemia, digitalis toxicity, chronic lung disease, acute ischemia or myocardial infarction, excessive caffeine, nicotine or alcohol use, amphetamine use, stress, valvular heart disease, pericarditis, heart failure (HF), hyperthyroidism, or inflammatory changes in the AV junction following heart surgery.</p><p class="headingAnchor" id="H538017237"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>The presence of PACs is associated with several characteristic findings on history, physical examination, and ECG.</p><p>PACs may be asymptomatic or cause symptoms such as a sensation of "skipping" or palpitations. PACs are often single and isolated, but they may be frequent and may occur in a bigeminal pattern. Although PACs have a wide array of manifestations, they are not life-threatening by themselves. In predisposed individuals, PACs may initiate supraventricular and, less commonly, ventricular arrhythmias, with AF being the most common arrhythmia induced by PACs [<a href="#rid32">32-35</a>].</p><p class="headingAnchor" id="H632922389"><span class="h2">Symptoms</span><span class="headingEndMark"> — </span>PACs produce few or no symptoms in the vast majority of patients (as is also the case in most persons with PVCs), although some individuals may experience palpitations or dizziness. PACs rarely cause true hemodynamic compromise, except when they are associated with an underlying bradycardia.</p><p>PACs may lead to palpitations (when there is a pause and increased left ventricular inotropy resulting from an increase in stroke volume) or the sensation of skipped beats which may be due to nonconducted PACs or ineffective contraction resulting from poor filling of the left ventricle during the premature beat. Atrial bigeminy with nonconducted PACs may lead to ventricular rates approaching 40 beats/min, possibly leading to symptoms (ie, lightheadedness, dizziness, presyncope) related to the bradyarrhythmia  (<a class="graphic graphic_waveform graphicRef72122" href="/z/d/graphic/72122.html" rel="external">waveform 1</a>).</p><p>Frequent PACs have been associated with a reversible cardiomyopathy in animal models, with rare case reports in humans, wherein patients with incessant PACs may present with symptoms of HF [<a href="#rid36">36</a>]. This is discussed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/1062.html" rel="external">"Arrhythmia-induced cardiomyopathy", section on 'Frequent atrial ectopy'</a>.)</p><p>Most subjects with junctional premature beats (JPBs), like most subjects with PACs, are asymptomatic. However, JPBs may lead to symptoms of palpitations or the sensation of skipped beats. Concealed JPBs that lead to second degree AV block may be associated with symptoms of lightheadedness or near syncope, particularly if they occur in a bigeminal pattern.</p><p class="headingAnchor" id="H632922412"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>The most characteristic finding on physical exam is the presence of an irregular pulse resulting from the presence of PACs or JPBs during the examination. Palpation of the peripheral pulse will demonstrate either premature pulse waves or pauses. Early PACs may lead to cannon A waves on the jugular venous pulsations as they may occur while the AV valves are still closed from the previous ventricular systole. This finding may be particularly helpful in differentiating early nonconducted PACs from sinus pauses. Auscultation of the heart may detect early heart sounds or pauses. PACs and JPBs may also lead to changes in the intensity or timing of a variety of cardiac murmurs (such as those due to mitral valve prolapse) due to the reduction in diastolic filling time and a reduction in ventricular volumes. These changes may be reversed with the post extrasystolic beat since there is an increase in ventricular volume due to the pause. (See  <a class="medical medical_review" href="/z/d/html/1078.html" rel="external">"Auscultation of cardiac murmurs in adults"</a>.)</p><p class="headingAnchor" id="H372318073"><span class="h2">Electrocardiography</span><span class="headingEndMark"> — </span>An ECG should be part of the standard evaluation for any patient with suspected PACs or JPBs.</p><p class="headingAnchor" id="H372318110"><span class="h3">ECG findings with APBs</span><span class="headingEndMark"> — </span>PACs are observed on the surface ECG as a P wave that occurs relatively early in the cardiac cycle (ie, prematurely before the next sinus P wave should occur) and has a different morphology and axis from the sinus P wave. Often the PR interval is different from that during sinus rhythm; it may be longer or shorter, depending upon the site of origin of the PAC. With faster baseline heart rates, the abnormal P wave may be hidden within the preceding T wave, producing a "peaked" or "camel hump" type of T wave. If this is not apparent to the interpreting clinician, the PAC may be mistaken for a JPB. (See  <a class="medical medical_review" href="/z/d/html/2118.html" rel="external">"ECG tutorial: Atrial and atrioventricular nodal (supraventricular) arrhythmias", section on 'Premature atrial complex'</a>.)</p><p>PACs may have a variety of manifestations on the ECG  (<a class="graphic graphic_waveform graphicRef96438" href="/z/d/graphic/96438.html" rel="external">waveform 2</a>), including: </p><p class="bulletIndent1"><span class="glyph">●</span>A normal QRS complex and a normal or short PR interval.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A normal QRS complex and a prolonged PR interval.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A conducted but aberrant (widened) QRS complex. In general, right bundle branch block aberrancy is more common than left bundle branch block aberrancy because of the longer refractory period of the right bundle branch [<a href="#rid37">37</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>No QRS complex (nonconducted PAC)  (<a class="graphic graphic_waveform graphicRef77154" href="/z/d/graphic/77154.html" rel="external">waveform 3</a>).</p><p></p><p>The site of origin of an PAC can affect its conduction through the AV node and its P wave morphology:</p><p class="bulletIndent1"><span class="glyph">●</span>An PAC originating in the low right atrium near the AV node may result in a short PR interval (&lt;120 ms) and may even be mistaken for a junctional premature depolarization.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A negative P wave in the inferior leads, particularly aVF, suggests a low atrial focus, while a negative P wave in lead I and aVL suggests a left atrial origin.</p><p></p><p>The AV nodal conduction time, and therefore the PR interval, may also differ depending on the input pathway to the AV node. PACs that originate from the left atrium typically have shorter conduction times than those originating from the right atrium [<a href="#rid38">38</a>].</p><p>An incomplete compensatory pause follows an PAC due to resetting of the sinus node by the PAC, with the subsequent sinus beat occurring slightly earlier than would be expected in sinus rhythm (less than twice the sinus P-P interval). This is in contrast to the fully compensatory pause which is observed after a ventricular premature beat. Rarely, one may encounter interpolated PACs without a compensatory pause [<a href="#rid39">39</a>].</p><p>A nonconducted PAC, especially one that may be obscured by the T wave, may give the false appearance of a sinus pause or sinoatrial exit block  (<a class="graphic graphic_waveform graphicRef77154" href="/z/d/graphic/77154.html" rel="external">waveform 3</a>). Evaluation of multiple leads may be required to detect the PAC, since it may cause a discernible deflection, seen as a deformity of the normal T wave, in only one or a few ECG leads. (See  <a class="medical medical_review" href="/z/d/html/894.html" rel="external">"Sinoatrial nodal pause, arrest, and exit block"</a>.)</p><p class="headingAnchor" id="H372318292"><span class="h3">ECG findings with JPBs</span><span class="headingEndMark"> — </span>JPBs may have a variety of manifestations on the surface ECG. They are most often detected when there is a premature beat with a normal QRS complex <strong>and</strong>:</p><p class="bulletIndent1"><span class="glyph">●</span>A P wave with a PR interval that is too short to be considered to be conducted through the AV node  (<a class="graphic graphic_waveform graphicRef62336" href="/z/d/graphic/62336.html" rel="external">waveform 4</a>). Although the upper limits of the conduction times (PR interval) consistent with JPBs have not been defined, a premature complex with a PR interval less than 90 ms is unlikely to reflect a conducted PAC.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>No P wave. The absence of a P wave may be due to burial of the wave within the QRS complex or the lack of retrograde atrial activation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A P wave that occurs at the terminal portion of the QRS complex, within the ST segment, or on the T wave, depending upon the rate of retrograde conduction.</p><p></p><p>The location of the P wave relative to the QRS complex provides no definitive information regarding the site of origin within the AV junction; it is simply a manifestation of the relative anterograde and retrograde conduction velocities.</p><p>Like PACs, JPBs may conduct anterogradely with a functional or rate-related bundle branch block. In this setting, they may be indistinguishable on the ECG from premature ventricular depolarizations. In this setting, only intracardiac recording of His bundle activation will differentiate between these two possibilities. (See  <a class="medical medical_review" href="/z/d/html/980.html" rel="external">"Invasive diagnostic cardiac electrophysiology studies"</a>.)</p><p>JPBs may also conduct retrogradely to the atrium and demonstrate conduction block to the ventricles. In this setting, they are similar to PACs and are indistinguishable from nonconducted PACs on the surface ECG.</p><p class="headingAnchor" id="H372318472"><span class="h3">Ambulatory monitoring</span><span class="headingEndMark"> — </span>Patients with palpitations or other symptoms suggesting PACs, but an unrevealing physical examination and ECG, should undergo ambulatory monitoring. In evaluating patients with suspected PACs, 24 to 48 hours of ambulatory ECG monitoring significantly increases the likelihood of making the diagnosis, given the sporadic nature of PACs in most patients. In addition, 24-hour Holter monitoring is also the best accepted approach to quantifying the frequency of PACs as a percentage of total heart beats. (See  <a class="medical medical_review" href="/z/d/html/958.html" rel="external">"Ambulatory ECG monitoring", section on 'Indications'</a>.)</p><p class="headingAnchor" id="H372318412"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of an PAC is made when a P wave with a morphology different from that of the sinus P wave (inverted or biphasic) occurs earlier than the anticipated sinus P wave  (<a class="graphic graphic_waveform graphicRef66489" href="/z/d/graphic/66489.html" rel="external">waveform 5</a>). If the ectopic focus is near the sinus node, the P wave may be similar to that of the sinus P. However, every lead should be examined as subtle differences in morphology may be present.</p><p class="headingAnchor" id="H632922489"><span class="h1">EVALUATION</span><span class="headingEndMark"> — </span>The evaluation of patients with symptoms suggesting PACs (or JPBs) should focus on documenting their presence or absence with an ECG or some form of ambulatory cardiac monitoring. (See <a class="local">'Electrocardiography'</a> above.)</p><p>Once PACs (or JPBs) have been identified, an additional evaluation should be performed focusing on the presence or absence of underlying structural heart disease. For patients in whom PACs have been identified, the following evaluation should be performed:</p><p class="bulletIndent1"><span class="glyph">●</span>24-hour ambulatory (Holter) monitor to quantify the frequency of PACs and determine if they are monomorphic or multimorphic</p><p class="bulletIndent1"><span class="glyph">●</span>Echocardiography to assess cardiac structure and function</p><p></p><p>Further testing is indicated only when this initial evaluation identifies significant structural cardiac abnormalities that require further evaluation.</p><p class="headingAnchor" id="H7"><span class="h2">EP testing</span><span class="headingEndMark"> — </span>There are no indications for performing electrophysiology (EP) studies in patients with PACs. JPBs generally do not require invasive electrophysiologic investigation unless there is a question of infra-His conduction disease, as in the patient with "pseudo AV block" who may possibly have Mobitz II second-degree AV block. (See  <a class="medical medical_review" href="/z/d/html/910.html" rel="external">"Second-degree atrioventricular block: Mobitz type II"</a>.)</p><p>However, when PACs occur in a patient undergoing EP study for another reason, EP findings include an atrial activation sequence that is different from the sinus activation sequence, and normal conduction through the AV node and His-Purkinje system  (<a class="graphic graphic_waveform graphicRef70505" href="/z/d/graphic/70505.html" rel="external">waveform 6</a>). Additionally, functional bundle branch block may be seen, leading to HV interval prolongation. Nonconducted PACs typically demonstrate block at the AV node. (See  <a class="medical medical_review" href="/z/d/html/980.html" rel="external">"Invasive diagnostic cardiac electrophysiology studies"</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>In persons found to have frequent PACs or JPBs, further evaluation and management is based on the presence or absence of underlying structural heart disease and/or symptoms. The presence of frequent PACs should prompt a diagnostic evaluation for the possible presence of underlying structural heart disease, which has prognostic significance and may require specific therapy.</p><p>No therapy is required for PACs or JPBs in the asymptomatic individual. For patients with symptomatic PACs, simple reassurance regarding the benign nature of PACs is frequently adequate to alleviate symptoms. In addition, patients should be counselled to avoid or minimize potential PAC precipitants (ie, smoking, alcohol intake, stress, caffeine intake in patients whose symptoms are temporally related).</p><p>Options for therapy in patients with symptomatic PACs include medical therapy and, in patients with persistent symptoms, catheter ablation. However, there are few direct data to guide the choice of medical therapies, with most of the available data derived from case reports or small case series. Much of the rationale for the use of certain medications is drawn from their use in the treatment of other arrhythmias (eg, supraventricular tachyarrhythmias, PVCs). In addition, there are no studies that directly compare medical therapies with each other or with catheter ablation.</p><p>Due to their low frequency of JPBs and even rarer incidence of significant symptoms, the appropriate treatment of symptomatic JPBs has not been evaluated. Reassurance of the benign nature of this rhythm abnormality may alleviate symptoms. For patients with persistent, limiting symptoms due to JPBs, therapy is similar to that for PACs, with beta blockers as the primary option.</p><p class="headingAnchor" id="H632922797"><span class="h2">Medical therapy</span><span class="headingEndMark"> — </span>For patients with ongoing symptomatic PACs following efforts to minimize potential PAC precipitants (ie, smoking, caffeine intake, alcohol intake, stress), medical therapy with a beta blocker is recommended if no contraindication exists for its use (eg, oral <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">metoprolol</a> 25 mg twice daily with uptitration as needed for effect). Beta blockers can reduce the symptoms related to PACs and may reduce their frequency, particularly if they are due to enhanced automaticity related to enhanced sympathetic output. Beta blockers do not suppress PACs but may be useful to reduce symptoms by reducing the increased inotropy seen with the post extrasystolic beat (ie, post extrasystolic potentiation). The response to beta blockers is inconsistent and variable, with some patients having complete or near complete symptom resolution and others showing minimal benefit.</p><p>A cohort study examined whether beta blockers at low doses may improve long-term outcomes in individuals with PACs, stratified into high-burden (≥100 PACs/24 h) and low-burden (&lt;100 PACs/24 h) subcohorts [<a href="#rid40">40</a>]. In the high-burden subcohort, after propensity score matching, the treatment group (n = 208) had significantly lower mortality rates during mean follow-up of about three years than the nontreatment group (n = 832; hazard ratio [HR] 0.52, 95% CI 0.294-0.923), but rates of new stroke and of new AF were similar in the two groups. Similarly, in the low-burden subcohort, the treatment group (n = 614) had a 40 percent mortality reduction (HR 0.60, 95% CI 0.396-0.913) compared with the nontreatment group (n = 1228), but rates of new stroke and new AF were similar in the two groups. These findings suggest that beta blockers may decrease the mortality rate in patients with high or low burden of PACs, but this effect was not related to the risk of new stroke or new AF.</p><p>Type IA, type IC, and type III antiarrhythmic agents  (<a class="graphic graphic_table graphicRef120433" href="/z/d/graphic/120433.html" rel="external">table 1</a>) can diminish the frequency of PACs in the symptomatic patient. These drugs may also suppress PACs that precipitate or trigger other supraventricular arrhythmias including AF, atrial flutter, atrioventricular nodal reentrant tachycardia, or atrioventricular reentrant tachycardia. Although controlled studies have not been performed with many of these agents, several reports describe their successful use [<a href="#rid41">41-43</a>]. However, administration of these agents must be balanced with the risk of proarrhythmia. (See  <a class="medical medical_review" href="/z/d/html/1038.html" rel="external">"Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Clinical trials"</a> and  <a class="medical medical_review" href="/z/d/html/1035.html" rel="external">"Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Recommendations", section on 'Proarrhythmia'</a> and  <a class="medical medical_review" href="/z/d/html/86747.html" rel="external">"Major side effects of class I antiarrhythmic drugs"</a>.)</p><p>By comparison, <a class="drug drug_general" data-topicid="9360" href="/z/d/drug information/9360.html" rel="external">digoxin</a>, calcium channel blockers, and type IB antiarrhythmic agents have not been clearly shown to be beneficial in patients with symptomatic PACs.</p><p class="headingAnchor" id="H632922854"><span class="h2">Catheter ablation</span><span class="headingEndMark"> — </span>When PACs are symptomatic and documented to trigger AF, they may be a target for catheter ablation, particularly in patients with concern for cardiomyopathy due to frequent PACs or those with persistent PACs and symptoms in spite of medical therapy. (See  <a class="medical medical_review" href="/z/d/html/949.html" rel="external">"Atrial fibrillation: Catheter ablation"</a>.)</p><p>PACs arising from the pulmonary veins may be treated by pulmonary vein isolation. PACs of non-pulmonary vein origin may also be managed by ablation guided by electroanatomic mapping techniques [<a href="#rid44">44-47</a>]. Successful pulmonary vein isolation procedures in patients with paroxysmal AF and high trigger burden (approximately 500 PACs/h) not only reduce the trigger burden but also increase the PAC coupling interval, suggesting that shorter coupled PACs originate preferentially from the pulmonary veins, which has been considered a reflection of the pulmonary veins' abbreviated refractoriness in patients with AF [<a href="#rid48">48-50</a>].</p><p class="headingAnchor" id="H538018740"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>The prognosis related to PACs depends on the presence of any underlying cardiovascular pathology. However, the presence of PACs in populations of apparently healthy persons appears to be associated with a greater risk of cardiovascular morbidity and mortality.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiovascular mortality</strong> – Frequent PACs have been associated with greater risk of cardiovascular mortality [<a href="#rid51">51-55</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Among 7692 healthy participants with no history of myocardial infarction, stroke, AF, or atrial flutter enrolled in the prospective Japanese NIPPON DATA 90 cohort and followed for an average of 14 years, only 64 persons (0.8 percent) had one or more PACs on a screening 12-lead ECG at enrollment [<a href="#rid53">53</a>]. However, the presence of PACs was an independent predictor for cardiovascular (CV) deaths (hazard ratio [HR] 2.03, 95% CI 1.12-3.66).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Among 7504 healthy participants in the NHANES study without known CVD who were followed for up to 18 years, 89 persons (1.2 percent) had one or more PACs on a screening 12-lead ECG [<a href="#rid54">54</a>]. As seen in the Japanese study, the presence of PACs was associated with higher CV mortality (HR 1.78, 95% CI 1.26-2.44) as well as higher total mortality (HR 1.41, 95% CI 1.08-1.80).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Among 5371 consecutive Taiwanese patients without AF or a permanent pacemaker (PPM) at baseline who underwent 24-hour Holter monitoring, an PAC burden &gt;76 beats per day was an independent predictor of mortality (HR 1.4, 95% CI 1.2-1.6), cardiovascular hospitalization (HR 1.3; 95% CI 1.1-1.5), new-onset AF (HR 1.8, 95% CI 1.4-2.2), and PPM implantation (HR 2.8, 95% CI 1.9-4.2) over a mean follow-up of 10 years [<a href="#rid55">55</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A cohort study examined the distribution of PAC burden and its relationship to all-cause mortality and CV death in 15,893 persons [<a href="#rid56">56</a>]. PAC burden increased with age with no apparent sex difference. Multivariate analysis found that PAC burden was associated with the risk of all-cause mortality (4<sup>th</sup> versus 1<sup>st</sup> quartile, adjusted HR 1.67) and CV death (HR 1.12 per ln PAC increase). In subgroup analyses, the risk of high PAC burden (≥100 PACs/24 h) was consistent across the overall cohort and prespecified subgroups.</p><p></p><p class="bulletIndent1">Similar findings, though with a less magnitude of risk, have been seen in other smaller cohorts of patients who were evaluated with 24-hour Holter monitoring and who were stratified based on total numbers of PACs in 24 hours [<a href="#rid51">51,52</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>AF</strong> – Frequent PACs or increased PAC burden may predict new or undiagnosed AF and adverse cardiovascular events [<a href="#rid51">51,52,55,57-65</a>]. As examples:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a single-center cohort of 428 patients without AF or structural heart disease who were referred for 24-hour Holter monitoring to evaluate palpitations, dizziness, or syncope, 107 (25 percent) had frequent PACs (number of PACs at the top quartile, ie, &gt;100 PACs/day) [<a href="#rid51">51</a>]. After a mean of 6.1 years of follow-up, significantly more patients with frequent PACs developed AF (31 patients [29 percent] compared with 29 patients [9 percent] with less frequent PACs).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a subset of the prospective Cardiovascular Health Study, 1260 adults without prevalent AF who enrolled between 1989 and 1990 underwent 24-hour Holter monitoring and were followed for 15 years. Using the Framingham AF risk algorithm, doubling of the hourly PAC count was associated with a significant increase in AF risk (HR 1.17, 95% CI 1.13-1.22) [<a href="#rid52">52</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a Japanese cohort of 63,197 persons without known CVD at baseline who were followed for an average of 14 years, the presence of PACs on baseline ECG was associated with a significantly higher likelihood of developing AF in both men (HR 4.9, 95% CI 3.6-6.6) and women (HR 3.9, 95% CI 2.7-5.6) [<a href="#rid59">59</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a retrospective cohort, which analyzed Holter recordings from 1357 veterans free of AF at baseline (mean age 64 years; 93 percent men), with a median follow-up of 7.5 years, AF was significantly more common in patients with frequent (≥100/day) PACs compared with patients with infrequent (&lt;100/day) PACs (22 versus 6 percent, adjusted HR 3.0, 95% CI 1.9-4.8) [<a href="#rid60">60</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In the STROKESTOP I mass-screening study for AF in 75- and 76-year-old persons in Sweden, over a median follow-up of 4.2 years, of the 6100 participants, 15 percent (n = 894) had arrhythmia, with frequent PACs being the most common (11.6 percent; n = 709) and irregular supraventricular tachycardias being more common than regular [<a href="#rid66">66</a>]. Persons with the most AF-similar supraventricular tachycardias, irregular and lacking p waves (1.6 percent; n = 97), had the highest risk of developing AF (HR 4.3) and an increased risk of death (HR 2.0). Thus, progression of atrial arrhythmias from PACs to more AF-like episodes was associated with development of AF, suggesting a possible role for screening for AF in individuals with frequent supraventricular activity.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Frequent PACs during exercise (&gt;5 beats per stage) provided prognostic information with a higher incidence (5.5 percent) of new-onset AF/atrial flutter at follow-up (approximately one year) in 128 patients compared with 870 patients with no frequent PACs (0.6 percent AF/atrial flutter incidence) [<a href="#rid67">67</a>]. Treadmill-induced frequent PACs, chronotropic incompetence, and palpitation as a reason for treadmill testing were independent risk factors that predicted new-onset AF/atrial flutter.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Higher numbers of PACs have also been shown to be a predictor of subclinical AF in patients with cryptogenic stroke as well as a predictor of late AF recurrence following pulmonary vein isolation for AF [<a href="#rid62">62,63</a>]. (See  <a class="medical medical_review" href="/z/d/html/1090.html" rel="external">"Cryptogenic stroke and embolic stroke of undetermined source (ESUS)"</a> and  <a class="medical medical_review" href="/z/d/html/949.html" rel="external">"Atrial fibrillation: Catheter ablation"</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>In a meta-analysis of 12 studies with a total of 109,689 subjects with frequent (n = 9217) and non-frequent (n = 100,472) PACs, patients with frequent PACs, however variably defined, had an increased risk of new onset AF (pooled risk ratio 2.8, 95% CI 2.1-3.7) [<a href="#rid68">68</a>].</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>In a study of 4331 participants with hypertension and receiving treatment, AF risk associated with PACs could potentially be decreased by treatment with angiotensin-II receptor blockers (ARBs) and statins, along with lowering blood pressure and managing diabetes [<a href="#rid69">69</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stroke</strong> – There are mixed data on the risk of stroke in patients with PACs, with some studies suggesting a higher risk of stroke in patients with frequent PACs [<a href="#rid27">27,28,70,71</a>] while others have found no such increase in risk [<a href="#rid72">72</a>]. Because not all of the studies presented data on the development of AF during follow-up, and AF is definitively associated with an increased risk of stroke, the impact of frequent PACs on stroke risk remains uncertain. However, in patients with acute stroke, the presence of numerous PACs and short runs of supraventricular tachycardia have been associated with a greater risk for subsequently developing AF, which might potentially explain the etiology of the stroke [<a href="#rid73">73-75</a>]. Furthermore, the concept that atrial myopathy might play a role and be responsible for a stroke in some patients independently from AF has also been advanced, and frequent or an excessive burden of PACs (≥30 PACs/h daily or any runs of ≥20 PACs) might constitute an ECG marker for such a myopathy [<a href="#rid26">26,27</a>].</p><p></p><p class="bulletIndent1">A meta-analysis of 12 studies examining whether PACs can predict AF in 2340 ischemic stroke patients (mean age 66 years) indicated that PACs were highly associated with AF occurrence in stroke (pooled odds ratio [OR] 4.16, 95% CI 3.06-5.65) and cryptogenic stroke patients (pooled OR 3.72, 95% CI 2.66-5.20) [<a href="#rid76">76</a>]. Subgroup analysis showed that PAC presence (pooled OR 3.72, 95% 1.65-8.36) and frequent PACs (pooled OR 5.12, 95% CI 3.12-8.41) were correlated with stroke in AF patients. Frequent PACs were identified as the risks for asymptomatic AF (OR 6.18, 95% CI 3.23-11.83) and future AF occurrence (OR 3.71, 95% CI 2.62-5.26) in stroke patients.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sudden cardiac death</strong> – Isolated PACs have not been associated with sudden death (SCD). Among 14,574 patients in the ARIC study who had a 12-lead ECG and a two-minute 3-lead rhythm strip at baseline, there was no significant increase in the risk of SCD among persons with PACs (HR 1.15, 95% CI 0.56-2.39), although when PACs occur concurrently in individuals with VPBs, the risk of SCD was higher (HR 6.39 compared with patients with neither PACs nor VPBs; 95% CI 2.58-15.84) [<a href="#rid77">77</a>].</p><p></p><p class="headingAnchor" id="H3919491787"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/116932.html" rel="external">"Society guideline links: Catheter ablation of arrhythmias"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/116931.html" rel="external">"Society guideline links: Supraventricular arrhythmias"</a>.)</p><p class="headingAnchor" id="H5230411"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Supraventricular premature beats represent premature activation of the atria from a site other than the sinus node. The vast majority originate from the atria (premature atrial complexes [PACs]) though some originate from the atrioventricular node (called junctional premature beats [JPBs]). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence</strong> – PACs are fairly ubiquitous, occurring commonly in both young and older adult subjects and in those with and without significant heart disease. JPBs occur less commonly than both PACs and premature ventricular complexes/contractions (PVCs) and are rarely seen in clinical practice. (See <a class="local">'Prevalence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Symptoms and signs</strong> – PACs and JPBs are asymptomatic in the vast majority of patients but can cause symptoms such as a sensation of "skipping" or palpitations. The most characteristic physical exam finding is an irregular pulse. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic evaluation</strong> – The evaluation of patients with suspected PACs (or JPBs) should focus on documenting their presence or absence with an ECG or ambulatory cardiac monitoring.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>PACs</strong> – These are observed on the surface ECG as a P wave that occurs earlier than the anticipated next sinus P wave and has a different morphology (eg, inverted or biphasic) from the sinus P wave  (<a class="graphic graphic_waveform graphicRef72122" href="/z/d/graphic/72122.html" rel="external">waveform 1</a> and <a class="graphic graphic_waveform graphicRef96438" href="/z/d/graphic/96438.html" rel="external">waveform 2</a> and <a class="graphic graphic_waveform graphicRef77154" href="/z/d/graphic/77154.html" rel="external">waveform 3</a> and <a class="graphic graphic_waveform graphicRef66489" href="/z/d/graphic/66489.html" rel="external">waveform 5</a>). Every lead should be examined as subtle differences in morphology may be present. Often the PR interval is different from that during sinus rhythm. (See <a class="local">'ECG findings with APBs'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>JPBs</strong> – These are observed on the ECG as a QRS complex with no preceding P wave or with a P wave occurring too soon before the QRS to be considered to be conducted through the AV node  (<a class="graphic graphic_waveform graphicRef62336" href="/z/d/graphic/62336.html" rel="external">waveform 4</a>). (See <a class="local">'ECG findings with JPBs'</a> above.)</p><p></p><p class="bulletIndent1">Once PACs (or JPBs  (<a class="graphic graphic_waveform graphicRef62336" href="/z/d/graphic/62336.html" rel="external">waveform 4</a>)) have been identified, additional evaluation should be performed to identify any underlying structural heart disease. (See <a class="local">'Evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – In persons with frequent PACs or JPBs, management is based on the presence or absence of symptoms and/or underlying structural heart disease. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Asymptomatic PACs or JPBs</strong> – No therapy is required for PACs or JPBs in the asymptomatic individual.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Symptomatic PACs</strong> – For patients with symptomatic PACs, reassurance regarding the benign nature of PACs is frequently adequate to alleviate symptoms. In addition, patients should be counseled to avoid or minimize potential PAC precipitants (eg, smoking, alcohol intake, stress, caffeine intake, obesity, poor physical activity).</p><p></p><p class="bulletIndent2">For patients with persistent symptomatic PACs despite efforts to minimize potential PAC precipitants we suggest a trial of medical therapy with a beta blocker (eg, oral <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">metoprolol</a> 25 mg twice daily with uptitration as needed for effect) (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). </p><p></p><p class="bulletIndent2">When PACs are symptomatic and documented to trigger atrial fibrillation (AF) or persist despite medical therapy, they may be a target for catheter ablation, particularly in patients with concern for cardiomyopathy due to frequent PACs. (See <a class="local">'Catheter ablation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Symptomatic JPBs</strong> – Reassurance of the benign nature of this rhythm abnormality may alleviate symptoms. For patients with persistent, limiting symptoms due to JPBs, therapy is similar to that for PACs, with beta blockers as the primary option.</p><p></p><p class="headingAnchor" id="H416771746"><span class="h1">ACKNOWLEDGMENTS</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Philip Podrid, MD, FACC, and Bernard Gersh, MB, ChB, DPhil, FRCP, MACC, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Conen D, Adam M, Roche F, et al. Premature atrial contractions in the general population: frequency and risk factors. Circulation 2012; 126:2302.</a></li><li><a class="nounderline abstract_t">Southall DP, Richards J, Mitchell P, et al. Study of cardiac rhythm in healthy newborn infants. Br Heart J 1980; 43:14.</a></li><li><a class="nounderline abstract_t">Folarin VA, Fitzsimmons PJ, Kruyer WB. Holter monitor findings in asymptomatic male military aviators without structural heart disease. Aviat Space Environ Med 2001; 72:836.</a></li><li><a class="nounderline abstract_t">Rossi A. Twenty-four-hour electrocardiographic study in the active very elderly. Cardiology 1987; 74:159.</a></li><li><a class="nounderline abstract_t">Larsen BS, Kumarathurai P, Nielsen OW, Sajadieh A. The circadian variation of premature atrial contractions. Europace 2016; 18:1573.</a></li><li><a class="nounderline abstract_t">WALLACE AG, DAGGETT WM. RE-EXCITATION OF THE ATRIUM. "THE ECHO PHENOMENON". Am Heart J 1964; 68:661.</a></li><li><a class="nounderline abstract_t">DE CARVALHO AP, DE MELLO WC, HOFFMAN BF. Electrophysiological evidence for specialized fiber types in rabbit atrium. Am J Physiol 1959; 196:483.</a></li><li><a class="nounderline abstract_t">Wit AL, Cranefield PF. Triggered and automatic activity in the canine coronary sinus. Circ Res 1977; 41:434.</a></li><li><a class="nounderline abstract_t">KILLIP T, GAULT JH. MODE OF ONSET OF ATRIAL FIBRILLATION IN MAN. Am Heart J 1965; 70:172.</a></li><li><a class="nounderline abstract_t">Vincenti A, Brambilla R, Fumagalli MG, et al. Onset mechanism of paroxysmal atrial fibrillation detected by ambulatory Holter monitoring. Europace 2006; 8:204.</a></li><li><a class="nounderline abstract_t">Davis MJ, Hockings BE, el Dessouky MA, et al. Cigarette smoking and ventricular arrhythmia in coronary heart disease. Am J Cardiol 1984; 54:282.</a></li><li><a class="nounderline abstract_t">Ettinger PO, Wu CF, De La Cruz C Jr, et al. Arrhythmias and the "Holiday Heart": alcohol-associated cardiac rhythm disorders. Am Heart J 1978; 95:555.</a></li><li><a class="nounderline abstract_t">Dobmeyer DJ, Stine RA, Leier CV, et al. The arrhythmogenic effects of caffeine in human beings. N Engl J Med 1983; 308:814.</a></li><li><a class="nounderline abstract_t">Enriquez A, Frankel DS. Arrhythmogenic effects of energy drinks. J Cardiovasc Electrophysiol 2017; 28:711.</a></li><li><a class="nounderline abstract_t">Voskoboinik A, Kalman JM, Kistler PM. Caffeine and Arrhythmias: Time to Grind the Data. JACC Clin Electrophysiol 2018; 4:425.</a></li><li><a class="nounderline abstract_t">Dixit S, Stein PK, Dewland TA, et al. Consumption of Caffeinated Products and Cardiac Ectopy. J Am Heart Assoc 2016; 5.</a></li><li><a class="nounderline abstract_t">Bittar G, Friedman HS. The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest 1991; 99:1415.</a></li><li><a class="nounderline abstract_t">Sessler CN, Cohen MD. Cardiac arrhythmias during theophylline toxicity. A prospective continuous electrocardiographic study. Chest 1990; 98:672.</a></li><li><a class="nounderline abstract_t">Krishnappa D, Wang W, Rooney MR, et al. Life's Simple 7 cardiovascular health score and premature atrial contractions: The atherosclerosis risk in communities (ARIC) study. Int J Cardiol 2021; 332:70.</a></li><li><a class="nounderline abstract_t">Rechavia E, Strasberg B, Mager A, et al. The incidence of atrial arrhythmias during inferior wall myocardial infarction with and without right ventricular involvement. Am Heart J 1992; 124:387.</a></li><li><a class="nounderline abstract_t">Zoni Berisso M, Ferroni A, De Caro E, et al. Clinical significance of supraventricular tachyarrhythmias after acute myocardial infarction. Eur Heart J 1986; 7:743.</a></li><li><a class="nounderline abstract_t">Bunch TJ, Chandrasekaran K, Gersh BJ, et al. The prognostic significance of exercise-induced atrial arrhythmias. J Am Coll Cardiol 2004; 43:1236.</a></li><li><a class="nounderline abstract_t">Ramsdale DR, Arumugam N, Singh SS, et al. Holter monitoring in patients with mitral stenosis and sinus rhythm. Eur Heart J 1987; 8:164.</a></li><li><a class="nounderline abstract_t">Lazzeroni E, Domenicucci S, Finardi A, et al. Severity of arrhythmias and extent of hypertrophy in hypertrophic cardiomyopathy. Am Heart J 1989; 118:734.</a></li><li><a class="nounderline abstract_t">Shen MJ, Arora R, Jalife J. Atrial Myopathy. JACC Basic Transl Sci 2019; 4:640.</a></li><li><a class="nounderline abstract_t">Sajeev JK, Kalman JM, Dewey H, et al. The Atrium and Embolic Stroke: Myopathy Not Atrial Fibrillation as the Requisite Determinant? JACC Clin Electrophysiol 2020; 6:251.</a></li><li><a class="nounderline abstract_t">Larsen BS, Kumarathurai P, Falkenberg J, et al. Excessive Atrial Ectopy and Short Atrial Runs Increase the Risk of Stroke Beyond Incident Atrial Fibrillation. J Am Coll Cardiol 2015; 66:232.</a></li><li><a class="nounderline abstract_t">Sajeev JK, Koshy AN, Dewey H, et al. Association between excessive premature atrial complexes and cryptogenic stroke: results of a case-control study. BMJ Open 2019; 9:e029164.</a></li><li><a class="nounderline abstract_t">Manolis AS, Manolis AA, Manolis TA, Melita H. Cardiac amyloidosis: An underdiagnosed/underappreciated disease. Eur J Intern Med 2019; 67:1.</a></li><li><a class="nounderline abstract_t">John AG, Hirsch GA, Stoddard MF. Frequent premature atrial contractions impair left atrial contractile function and promote adverse left atrial remodeling. Echocardiography 2018; 35:1310.</a></li><li><a class="nounderline abstract_t">Kusunoki Y, Nakamura T, Hattori K, et al. Atrial and Ventricular Arrhythmia-Associated Factors in Stable Patients with Chronic Obstructive Pulmonary Disease. Respiration 2016; 91:34.</a></li><li><a class="nounderline abstract_t">Bennett MA, Pentecost BL. The pattern of onset and spontaneous cessation of atrial fibrillation in man. Circulation 1970; 41:981.</a></li><li><a class="nounderline abstract_t">Durrer D, Schoo L, Schuilenburg RM, Wellens HJ. The role of premature beats in the initiation and the termination of supraventricular tachycardia in the Wolff-Parkinson-White syndrome. Circulation 1967; 36:644.</a></li><li><a class="nounderline abstract_t">Nallasivan M, Appel RA, Welch WJ, Bauernfeind RA. Ventricular tachycardia due to bundle branch reentry: induction by spontaneous atrial premature beats. Am Heart J 1988; 116:552.</a></li><li><a class="nounderline abstract_t">Berman ND. Ventricular tachycardia initiated by both normally and aberrantly conducted atrial premature beats. Pacing Clin Electrophysiol 1980; 3:519.</a></li><li><a class="nounderline abstract_t">Vervueren PL, Delmas C, Berry M, et al. Reversal of Dilated Cardiomyopathy After Successful Radio-Frequency Ablation of Frequent Atrial Premature Beats, a New Cause for Arrhythmia-Induced Cardiomyopathy. J Atr Fibrillation 2012; 5:627.</a></li><li><a class="nounderline abstract_t">MOE GK, MENDEZ C, HAN J. ABERRANT A-V IMPULSE PROPAGATION IN THE DOG HEART: A STUDY OF FUNCTIONAL BUNDLE BRANCH BLOCK. Circ Res 1965; 16:261.</a></li><li><a class="nounderline abstract_t">Batsford WP, Akhtar M, Caracta AR, et al. Effect of atrial stimulation site on the electrophysiological properties of the atrioventricular node in man. Circulation 1974; 50:283.</a></li><li><a class="nounderline abstract_t">Carbone V, Marafioti V, Oreto G. An unusual narrow QRS complex tachycardia: what is the mechanism? Ann Noninvasive Electrocardiol 2015; 20:94.</a></li><li><a class="nounderline abstract_t">Huang TC, Lee PT, Huang MS, et al. The Beneficial Effects of Beta Blockers on the Long-Term Prognosis of Patients With Premature Atrial Complexes. Front Cardiovasc Med 2022; 9:806743.</a></li><li><a class="nounderline abstract_t">Arif M, Laidlaw JC, Oshrain C, et al. A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias. Angiology 1983; 34:393.</a></li><li><a class="nounderline abstract_t">Carrasco HA, Vicuña AV, Molina C, et al. Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage. Int J Cardiol 1985; 9:425.</a></li><li><a class="nounderline abstract_t">Coumel P, Leclercq JF, Assayag P. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. Am J Cardiol 1984; 54:60D.</a></li><li><a class="nounderline abstract_t">Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339:659.</a></li><li><a class="nounderline abstract_t">Haïssaguerre M, Shah DC, Jaïs P, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000; 102:2463.</a></li><li><a class="nounderline abstract_t">Oral H, Knight BP, Tada H, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002; 105:1077.</a></li><li><a class="nounderline abstract_t">Yamada T, Murakami Y, Okada T, et al. Electroanatomic mapping in the catheter ablation of premature atrial contractions with a non-pulmonary vein origin. Europace 2008; 10:1320.</a></li><li><a class="nounderline abstract_t">Yamane T, Date T, Kanzaki Y, et al. Behavior of atrial ectopic beats before and after pulmonary vein isolation in patients with atrial fibrillation: a reduction in the number and arrhythmogenicity of ectopic firings. Heart Rhythm 2006; 3:1421.</a></li><li><a class="nounderline abstract_t">Brooks AG, Rangnekar G, Ganesan AN, et al. Characteristics of ectopic triggers associated with paroxysmal and persistent atrial fibrillation: evidence for a changing role. Heart Rhythm 2012; 9:1367.</a></li><li><a class="nounderline abstract_t">Jaïs P, Hocini M, Macle L, et al. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 2002; 106:2479.</a></li><li><a class="nounderline abstract_t">Chong BH, Pong V, Lam KF, et al. Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events. Europace 2012; 14:942.</a></li><li><a class="nounderline abstract_t">Dewland TA, Vittinghoff E, Mandyam MC, et al. Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study. Ann Intern Med 2013; 159:721.</a></li><li><a class="nounderline abstract_t">Inohara T, Kohsaka S, Okamura T, et al. Long-term outcome of healthy participants with atrial premature complex: a 15-year follow-up of the NIPPON DATA 90 cohort. PLoS One 2013; 8:e80853.</a></li><li><a class="nounderline abstract_t">Qureshi W, Shah AJ, Salahuddin T, Soliman EZ. Long-term mortality risk in individuals with atrial or ventricular premature complexes (results from the Third National Health and Nutrition Examination Survey). Am J Cardiol 2014; 114:59.</a></li><li><a class="nounderline abstract_t">Lin CY, Lin YJ, Chen YY, et al. Prognostic Significance of Premature Atrial Complexes Burden in Prediction of Long-Term Outcome. J Am Heart Assoc 2015; 4:e002192.</a></li><li><a class="nounderline abstract_t">Huang TC, Lee PT, Huang MS, et al. Higher premature atrial complex burden from the Holter examination predicts poor cardiovascular outcome. Sci Rep 2021; 11:12198.</a></li><li><a class="nounderline abstract_t">Suzuki S, Sagara K, Otsuka T, et al. Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation. Am J Cardiol 2013; 111:1602.</a></li><li><a class="nounderline abstract_t">Hashimoto M, Yamauchi A, Inoue S. Premature atrial contraction as a predictor of postoperative atrial fibrillation. Asian Cardiovasc Thorac Ann 2015; 23:153.</a></li><li><a class="nounderline abstract_t">Murakoshi N, Xu D, Sairenchi T, et al. Prognostic impact of supraventricular premature complexes in community-based health checkups: the Ibaraki Prefectural Health Study. Eur Heart J 2015; 36:170.</a></li><li><a class="nounderline abstract_t">Acharya T, Tringali S, Bhullar M, et al. Frequent Atrial Premature Complexes and Their Association With Risk of Atrial Fibrillation. Am J Cardiol 2015; 116:1852.</a></li><li><a class="nounderline abstract_t">Alhede C, Lauridsen TK, Johannessen A, et al. The impact of supraventricular ectopic complexes in different age groups and risk of recurrent atrial fibrillation after antiarrhythmic medication or catheter ablation. Int J Cardiol 2018; 250:122.</a></li><li><a class="nounderline abstract_t">Gladstone DJ, Dorian P, Spring M, et al. Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial. Stroke 2015; 46:936.</a></li><li><a class="nounderline abstract_t">Gang UJ, Nalliah CJ, Lim TW, et al. Atrial ectopy predicts late recurrence of atrial fibrillation after pulmonary vein isolation. Circ Arrhythm Electrophysiol 2015; 8:569.</a></li><li><a class="nounderline abstract_t">O'Neal WT, Kamel H, Judd SE, et al. Usefulness of Atrial Premature Complexes on Routine Electrocardiogram to Determine the Risk of Atrial Fibrillation (from the REGARDS Study). Am J Cardiol 2017; 120:782.</a></li><li><a class="nounderline abstract_t">Sasaki K, Nakajima I, Higuma T, et al. Revisit to the Prognostic Value of Premature Atrial Contraction Burden in 24-h Holter Electrocardiography for Predicting Undiagnosed Atrial Fibrillation　- A Propensity Score-Matched Study. Circ J 2021; 85:1265.</a></li><li><a class="nounderline abstract_t">Hygrell T, Stridh M, Friberg L, Svennberg E. Prognostic Implications of Supraventricular Arrhythmias. Am J Cardiol 2021; 151:57.</a></li><li><a class="nounderline abstract_t">Hwang JK, Gwag HB, Park SJ, et al. Frequent atrial premature complexes during exercise: A potent predictor of atrial fibrillation. Clin Cardiol 2018; 41:458.</a></li><li><a class="nounderline abstract_t">Prasitlumkum N, Rattanawong P, Limpruttidham N, et al. Frequent premature atrial complexes as a predictor of atrial fibrillation: Systematic review and meta-analysis. J Electrocardiol 2018; 51:760.</a></li><li><a class="nounderline abstract_t">Soliman EZ, Howard G, Judd S, et al. Factors Modifying the Risk of Atrial Fibrillation Associated With Atrial Premature Complexes in Patients With Hypertension. Am J Cardiol 2020; 125:1324.</a></li><li><a class="nounderline abstract_t">Engstrom G, Hedblad B, Juul-Moller S, et al. Cardiac arrhythmias and stroke: increased risk in men with high frequency of atrial ectopic beats. Stroke 2001; 31:2925.</a></li><li><a class="nounderline abstract_t">Pinho J, Braga CG, Rocha S, et al. Atrial ectopic activity in cryptogenic ischemic stroke and TIA: a risk factor for recurrence. J Stroke Cerebrovasc Dis 2015; 24:507.</a></li><li><a class="nounderline abstract_t">Ofoma U, He F, Shaffer ML, et al. Premature cardiac contractions and risk of incident ischemic stroke. J Am Heart Assoc 2012; 1:e002519.</a></li><li><a class="nounderline abstract_t">Kochhäuser S, Dechering DG, Dittrich R, et al. Supraventricular premature beats and short atrial runs predict atrial fibrillation in continuously monitored patients with cryptogenic stroke. Stroke 2014; 45:884.</a></li><li><a class="nounderline abstract_t">Weber-Krüger M, Gröschel K, Mende M, et al. Excessive supraventricular ectopic activity is indicative of paroxysmal atrial fibrillation in patients with cerebral ischemia. PLoS One 2013; 8:e67602.</a></li><li><a class="nounderline abstract_t">Wallmann D, Tüller D, Wustmann K, et al. Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients: an opportunity for a new diagnostic strategy. Stroke 2007; 38:2292.</a></li><li><a class="nounderline abstract_t">Tao Y, Xu J, Gong X, et al. Premature atrial complexes can predict atrial fibrillation in ischemic stroke patients: A systematic review and meta-analysis. Pacing Clin Electrophysiol 2021; 44:1599.</a></li><li><a class="nounderline abstract_t">Cheriyath P, He F, Peters I, et al. Relation of atrial and/or ventricular premature complexes on a two-minute rhythm strip to the risk of sudden cardiac death (the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 2011; 107:151.</a></li></ol></div><div id="topicVersionRevision">Topic 932 Version 36.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23048073" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Premature atrial contractions in the general population: frequency and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7356857" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Study of cardiac rhythm in healthy newborn infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11565820" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Holter monitor findings in asymptomatic male military aviators without structural heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3568057" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Twenty-four-hour electrocardiographic study in the active very elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26705556" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The circadian variation of premature atrial contractions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14222404" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : RE-EXCITATION OF THE ATRIUM. "THE ECHO PHENOMENON".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13627208" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Electrophysiological evidence for specialized fiber types in rabbit atrium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/902353" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Triggered and automatic activity in the canine coronary sinus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14328002" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : MODE OF ONSET OF ATRIAL FIBRILLATION IN MAN.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16627441" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Onset mechanism of paroxysmal atrial fibrillation detected by ambulatory Holter monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6465006" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Cigarette smoking and ventricular arrhythmia in coronary heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/636996" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Arrhythmias and the "Holiday Heart": alcohol-associated cardiac rhythm disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6835272" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The arrhythmogenic effects of caffeine in human beings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28387431" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Arrhythmogenic effects of energy drinks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30067480" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Caffeine and Arrhythmias: Time to Grind the Data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26813889" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Consumption of Caffeinated Products and Cardiac Ectopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2036824" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2394145" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Cardiac arrhythmias during theophylline toxicity. A prospective continuous electrocardiographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33675888" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Life's Simple 7 cardiovascular health score and premature atrial contractions: The atherosclerosis risk in communities (ARIC) study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1378995" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The incidence of atrial arrhythmias during inferior wall myocardial infarction with and without right ventricular involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3769957" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Clinical significance of supraventricular tachyarrhythmias after acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15063436" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The prognostic significance of exercise-induced atrial arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2436916" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Holter monitoring in patients with mitral stenosis and sinus rhythm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2529748" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Severity of arrhythmias and extent of hypertrophy in hypertrophic cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31768479" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Atrial Myopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32192674" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The Atrium and Embolic Stroke: Myopathy Not Atrial Fibrillation as the Requisite Determinant?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26184616" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Excessive Atrial Ectopy and Short Atrial Runs Increase the Risk of Stroke Beyond Incident Atrial Fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31371294" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Association between excessive premature atrial complexes and cryptogenic stroke: results of a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31375251" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Cardiac amyloidosis: An underdiagnosed/underappreciated disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29886569" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Frequent premature atrial contractions impair left atrial contractile function and promote adverse left atrial remodeling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26695820" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Atrial and Ventricular Arrhythmia-Associated Factors in Stable Patients with Chronic Obstructive Pulmonary Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5482912" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The pattern of onset and spontaneous cessation of atrial fibrillation in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6050923" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The role of premature beats in the initiation and the termination of supraventricular tachycardia in the Wolff-Parkinson-White syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2456683" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Ventricular tachycardia due to bundle branch reentry: induction by spontaneous atrial premature beats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6160549" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Ventricular tachycardia initiated by both normally and aberrantly conducted atrial premature beats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28496791" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Reversal of Dilated Cardiomyopathy After Successful Radio-Frequency Ablation of Frequent Atrial Premature Beats, a New Cause for Arrhythmia-Induced Cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14268448" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : ABERRANT A-V IMPULSE PROPAGATION IN THE DOG HEART: A STUDY OF FUNCTIONAL BUNDLE BRANCH BLOCK.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4846636" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Effect of atrial stimulation site on the electrophysiological properties of the atrioventricular node in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25039360" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : An unusual narrow QRS complex tachycardia: what is the mechanism?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35252388" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The Beneficial Effects of Beta Blockers on the Long-Term Prognosis of Patients With Premature Atrial Complexes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6408949" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3908329" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6208770" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9725923" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11076817" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Electrophysiological breakthroughs from the left atrium to the pulmonary veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11877358" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18755757" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Electroanatomic mapping in the catheter ablation of premature atrial contractions with a non-pulmonary vein origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17161784" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Behavior of atrial ectopic beats before and after pulmonary vein isolation in patients with atrial fibrillation: a reduction in the number and arrhythmogenicity of ectopic firings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22484650" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Characteristics of ectopic triggers associated with paroxysmal and persistent atrial fibrillation: evidence for a changing role.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12417546" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22183750" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24297188" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24260495" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Long-term outcome of healthy participants with atrial premature complex: a 15-year follow-up of the NIPPON DATA 90 cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24819898" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Long-term mortality risk in individuals with atrial or ventricular premature complexes (results from the Third National Health and Nutrition Examination Survey).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26316525" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Prognostic Significance of Premature Atrial Complexes Burden in Prediction of Long-Term Outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34108588" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Higher premature atrial complex burden from the Holter examination predicts poor cardiovascular outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23499279" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24838235" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Premature atrial contraction as a predictor of postoperative atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25358506" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Prognostic impact of supraventricular premature complexes in community-based health checkups: the Ibaraki Prefectural Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26611122" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Frequent Atrial Premature Complexes and Their Association With Risk of Atrial Fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29050922" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : The impact of supraventricular ectopic complexes in different age groups and risk of recurrent atrial fibrillation after antiarrhythmic medication or catheter ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25700289" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25904494" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Atrial ectopy predicts late recurrence of atrial fibrillation after pulmonary vein isolation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28705381" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Usefulness of Atrial Premature Complexes on Routine Electrocardiogram to Determine the Risk of Atrial Fibrillation (from the REGARDS Study).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33790146" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Revisit to the Prognostic Value of Premature Atrial Contraction Burden in 24-h Holter Electrocardiography for Predicting Undiagnosed Atrial Fibrillation　- A Propensity Score-Matched Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34167689" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Prognostic Implications of Supraventricular Arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29663455" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Frequent atrial premature complexes during exercise: A potent predictor of atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30177309" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Frequent premature atrial complexes as a predictor of atrial fibrillation: Systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32139160" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Factors Modifying the Risk of Atrial Fibrillation Associated With Atrial Premature Complexes in Patients With Hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11108750" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Cardiac arrhythmias and stroke: increased risk in men with high frequency of atrial ectopic beats</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25533759" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Atrial ectopic activity in cryptogenic ischemic stroke and TIA: a risk factor for recurrence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23316293" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Premature cardiac contractions and risk of incident ischemic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24425117" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Supraventricular premature beats and short atrial runs predict atrial fibrillation in continuously monitored patients with cryptogenic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23840747" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Excessive supraventricular ectopic activity is indicative of paroxysmal atrial fibrillation in patients with cerebral ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17585079" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients: an opportunity for a new diagnostic strategy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34170567" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Premature atrial complexes can predict atrial fibrillation in ischemic stroke patients: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21211594" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Relation of atrial and/or ventricular premature complexes on a two-minute rhythm strip to the risk of sudden cardiac death (the Atherosclerosis Risk in Communities [ARIC] study).</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
